Tirzepatide
Dual GIP and GLP-1 receptor agonist studied for metabolic and body-weight regulation.
Metabolic Retatrutide (GGG Tri-Agonist)
Triple-receptor agonist (GLP-1 / GIP / glucagon) studied for metabolic and body-weight regulation.
For research use only. Not for human consumption.
Retatrutide is a single-molecule agonist of the GLP-1, GIP, and glucagon receptors. It is among the most actively studied next-generation incretin peptides in metabolic research, where investigators examine its effects on energy balance, appetite signalling, and glucose handling in model systems.
Questions
No. Everything we sell is supplied strictly for in-vitro laboratory research. It is not for human or animal consumption, and not for any clinical, diagnostic, or therapeutic use.
Yes. Products are third-party tested, with full COA documentation available on request — showing identity, purity, and result.
Our peptides are third-party tested to 99%+ purity by HPLC.
Orders ship from the USA in discreet, tracked packaging, typically within 2–3 business days. Shipping is free on orders over $250.
Store lyophilised vials cool and dry, away from light; shelf life varies by product. Once reconstituted, keep refrigerated and follow your own research protocol.